Table 2

Direct medical and productivity costs included into the fesoterodine economic model

Resource costs

Costs

Source

Cost per incontinence pad

0.58 €

[43]

Cost of general practitioner visit

26.78 €

[44]

Cost of specialist visit

58.60 €

[44]

Cost of laboratory tests (urinalysis)

2.56 €

[44]

Constipation cost/day^a

0.16 €

[44]

Fesoterodine 4 mg (cost/day, with taxes)

1.70 €

[43]

Fesoterodine 8 mg (cost/day, with taxes)

2.72 €

[43]

Tolterodine ER (cost/day, with taxes)

1.70 €

[43]

Solifenacin 5 mg (cost/day, with taxes)

1.67 €

[43]

Solifenacin 10 mg (cost/day, with taxes)

2.67 €

[43]

Fracture

5,742.8 €

[45]

Skin Infection episode

53.1 €

[44]

Urinary Tract Infection episode

53.1 €

[44]

Depression (€/patient/year)

2,699 €

[46]

Nursing Home

14,831.4

[44]

Average hourly wage

13.51 €

[47]

Average number of hours worked per week

40

[47]

% Employed in population

59.83%

[47]

Decrease in hours worked due to incontinence ^b

21.1%

[33]

Reduced daytime productivity due to nocturia ^c

9.2%

[34]

^aThe mean cost/day per patient of managing constipation includes a daily dose of oral laxative. ^bWomen without incontinence report working 38 hours/week vs. 30 hours for women with incontinence. ^c 13.8% work impairment for patients with nocturia vs. 4.61% impairment for controls.

Arlandis-Guzman et al. BMC Urology 2011 11:9   doi:10.1186/1471-2490-11-9